Transcriptional regulation of serine/threonine protein kinase (AKT) genes by glioma-associated oncogene homolog

Journal of Biological Chemistry

Volumn 288, Issue 21, 2013, Pages 15390-15401

  Agarwal, Nitin K ^a   Qu, Changju ^a   Kunkulla, Kranthi ^a   Liu, Yadong ^a   Vega, Francisco ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SIGNIFICANCE; CHROMATIN IMMUNOPRECIPITATION; DIFFUSE LARGE B-CELL LYMPHOMA; PUTATIVE BINDING SITES; SITE DIRECTED MUTAGENESIS; TRANSCRIPTIONAL LEVELS; TRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL TARGETS;

AMINO ACIDS; GENES; ONCOLOGY;

TRANSCRIPTION;

LUCIFERASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR GLI1;

AKT1 GENE; AKT2 GENE; AKT3 GENE; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INTERACTION; GLI1 GENE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

AKT; CELL DEATH; DIFFUSE LARGE B-CELL LYMPHOMA; GLI1; HEDGEHOG; LYMPHOMA; TRANSCRIPTION;

CELL LINE, TUMOR; CELL SURVIVAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84878215706     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.425249     Document Type: Article

References (53)

1. Armitage, J. O., and Weisenburger, D. D. (1998) New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J. Clin. Oncol. 16, 2780-2795 (Pubitemid 28363044)
2. Larouche, J. F., Berger, F., Chassagne-Clément, C., Ffrench, M., Callet-Bauchu, E., Sebban, C., Ghesquières, H., Broussais-Guillaumot, F., Salles, G., and Coiffier, B. (2010) Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome. J. Clin. Oncol. 28, 2094-2100
3. McMahon, A. P., Ingham, P. W., and Tabin, C. J. (2003) Developmental roles and clinical significance of hedgehog signaling. Curr. Top. Dev. Biol. 53, 1-114 (Pubitemid 137639458)
4. Taipale, J., and Beachy, P. A. (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354 (Pubitemid 32467044)
5. Singh, R. R., Kim, J. E., Davuluri, Y., Drakos, E., Cho-Vega, J. H., Amin, H. M., and Vega, F. (2010) Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 24, 1025-1036
6. Tang, T., Tang, J. Y., Li, D., Reich, M., Callahan, C. A., Fu, L., Yauch, R. L., Wang, F., Kotkow, K., Chang, K. S., Shpall, E., Wu, A., Rubin, L. L., Marsters, J. C., Jr., Epstein, E. H., Jr., Caro, I., and de Sauvage, F. J. (2011) Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. Clin. Cancer Res. 17, 3378-3387
7. Yauch, R. L., Dijkgraaf, G. J., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., Bazan, J. F., Kan, Z., Seshagiri, S., Hann, C. L., Gould, S. E., Low, J. A., Rudin, C. M., and de Sauvage, F. J. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326, 572-574
8. Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., LoRusso, P. M., Von Hoff, D. D., de Sauvage, F. J., and Low, J. A. (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 361, 1173-1178
9. Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., Mackey, H. M., Lum, B. L., Darbonne, W. C., Marsters, J. C., Jr., de Sauvage, F. J., and Low, J. A. (2009) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med. 361, 1164-1172
10. Johnson, R. L., and Scott, M. P. (1998) New players and puzzles in the Hedgehog signaling pathway. Curr. Opin. Genet. Dev. 8, 450-456 (Pubitemid 28412463)
11. Kalderon, D. (2000) Transducing the hedgehog signal. Cell 103, 371-374
12. Taipale, J., Cooper, M. K., Maiti, T., and Beachy, P. A. (2002) Patched acts catalytically to suppress the activity of Smoothened. Nature 418, 892-897 (Pubitemid 34966310)
13. Varjosalo, M., and Taipale, J. (2008) Hedgehog: functions and mechanisms. Genes Dev. 22, 2454-2472
14. Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., and Vogelstein, B. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236, 70-73 (Pubitemid 17056814)
15. Kinzler, K. W., and Vogelstein, B. (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol. Cell. Biol. 10, 634-642
16. Singh, R. R., Kunkalla, K., Qu, C., Schlette, E., Neelapu, S. S., Samaniego, F., and Vega, F. (2011) ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 30, 4874-4886
17. He, S., Wang, F., Yang, L., Guo, C., Wan, R., Ke, A., Xu, L., Hu, G., Xu, X., Shen, J., and Wang, X. (2011) Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. PLoS One 6, e27684
18. Wang, F., Xu, L., Guo, C., Ke, A., Hu, G., Xu, X., Mo, W., Yang, L., Huang, Y., He, S., and Wang, X. (2011) Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One 6, e18434
19. Laner-Plamberger, S., Kaser, A., Paulischta, M., Hauser-Kronberger, C., Eichberger, T., and Frischauf, A. M. (2009) Cooperation between GLI and JUN enhances transcription of JUN and selected GLI target genes. Oncogene 28, 1639-1651
20. Kuphal, S., Shaw-Hallgren, G., Eberl, M., Karrer, S., Aberger, F., Bosserhoff, A. K., and Massoumi, R. (2011) GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma. Oncogene 30, 4523-4530
21. Kim, J. E., Singh, R. R., Cho-Vega, J. H., Drakos, E., Davuluri, Y., Khokhar, F. A., Fayad, L., Medeiros, L. J., and Vega, F. (2009) Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod. Pathol. 22, 1312-1320
22. Ramirez, E., Singh, R. R., Kunkalla, K., Liu, Y., Qu, C., Cain, C., Multani, A. S., Lennon, P. A., Jackacky, J., Ho, M., Dawud, S., Gu, J., Yang, S., Hu, P. C., and Vega, F. (2012) Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma. Leuk. Res. 36, 1267-1273
23. Pasqualucci, L., Trifonov, V., Fabbri, G., Ma, J., Rossi, D., Chiarenza, A., Wells, V. A., Grunn, A., Messina, M., Elliot, O., Chan, J., Bhagat, G., Chadburn, A., Gaidano, G., Mullighan, C. G., Rabadan, R., and Dalla-Favera, R. (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830-837
24. Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., Jackman, S., Krzywinski, M., Scott, D. W., Trinh, D. L., Tamura-Wells, J., Li, S., Firme, M. R., Rogic, S., Griffith, M., Chan, S., Yakovenko, O., Meyer, I. M., Zhao, E. Y., Smailus, D., Moksa, M., Chittaranjan, S., Rimsza, L., Brooks- Wilson, A., Spinelli, J. J., Ben-Neriah, S., Meissner, B., Woolcock, B., Boyle, M., McDonald, H., Tam, A., Zhao, Y., Delaney, A., Zeng, T., Tse, K., Butterfield, Y., Birol, I., Holt, R., Schein, J., Horsman, D. E., Moore, R., Jones, S. J., Connors, J. M., Hirst, M., Gascoyne, R. D., and Marra, M. A. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298-303
25. Bacus, S. S., Altomare, D. A., Lyass, L., Chin, D. M., Farrell, M. P., Gurova, K., Gudkov, A., and Testa, J. R. (2002) AKT2 is frequently upregulated in HER-2/neu-positive breast cancers and may contribute to tumor aggressiveness by enhancing cell survival. Oncogene 21, 3532-3540
26. Testa, J. R., and Bellacosa, A. (2001) AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 98, 10983-10985 (Pubitemid 32928669)
27. Uddin, S., Hussain, A. R., Siraj, A. K., Manogaran, P. S., Al-Jomah, N. A., Moorji, A., Atizado, V., Al-Dayel, F., Belgaumi, A., El-Solh, H., Ezzat, A., Bavi, P., and Al-Kuraya, K. S. (2006) Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108, 4178-4186 (Pubitemid 44913290)
28. Alessi, D. R., and Cohen, P. (1998) Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8, 55-62 (Pubitemid 28122141)
29. Staal, S. P. (1987) Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 84, 5034-5037
30. Sun, M., Wang, G., Paciga, J. E., Feldman, R. I., Yuan, Z. Q., Ma, X. L., Shelley, S. A., Jove, R., Tsichlis, P. N., Nicosia, S. V., and Cheng, J. Q. (2001) AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159, 431-437 (Pubitemid 32751073)
31. Dihlmann, S., Kloor, M., Fallsehr, C., and von Knebel Doeberitz, M. (2005) Regulation of AKT1 expression by β-catenin/Tcf/Lef signaling in colorectal cancer cells. Carcinogenesis 26, 1503-1512 (Pubitemid 41236043)
32. Park, S., Kim, D., Kaneko, S., Szewczyk, K. M., Nicosia, S. V., Yu, H., Jove, R., and Cheng, J. Q. (2005) Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway. J. Biol. Chem. 280, 38932-38941 (Pubitemid 41713842)
33. Hasselblom, S., Hansson, U., Olsson, M., Torén, L., Bergström, A., Nilsson-Ehle, H., and Andersson, P. O. (2010) High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Br. J. Haematol. 149, 560-568
34. Gonzalez, E., and McGraw, T. E. (2009) The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle 8, 2502-2508
35. Baohua, Y., Xiaoyan, Z., Tiecheng, Z., Tao, Q., and Daren, S. (2008) Mutations of the PIK3CA gene in diffuse large B cell lymphoma. Diagn. Mol. Pathol. 17, 159-165
36. Sakai, A., Thieblemont, C., Wellmann, A., Jaffe, E. S., and Raffeld, M. (1998) PTEN gene alterations in lymphoid neoplasms. Blood 92, 3410-3415 (Pubitemid 28492352)
37. Lenz, G., Wright, G. W., Emre, N. C., Kohlhammer, H., Dave, S. S., Davis, R. E., Carty, S., Lam, L. T., Shaffer, A. L., Xiao, W., Powell, J., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Connors, J. M., Campo, E., Jaffe, E. S., Delabie, J., Smeland, E. B., Rimsza, L. M., Fisher, R. I., Weisenburger, D. D., Chan, W. C., and Staudt, L. M. (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. U.S.A. 105, 13520-13525
38. Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lin-Lee, Y. C., and Ford, R. J. (2005) Constitutive NF-κB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 106, 3940-3947 (Pubitemid 41739035)
39. Pham, L. V., Fu, L., Tamayo, A. T., Bueso-Ramos, C., Drakos, E., Vega, F., Medeiros, L. J., and Ford, R. J. (2011) Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Blood 117, 200-210
40. Schmittgen, T. D. (2001) Real-time quantitative PCR. Methods 25, 383-385
41. Singh, R. R., Cho-Vega, J. H., Davuluri, Y., Ma, S., Kasbidi, F., Milito, C., Lennon, P. A., Drakos, E., Medeiros, L. J., Luthra, R., and Vega, F. (2009) Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res. 69, 2550-2558
42. Boulbes, D., Chen, C. H., Shaikenov, T., Agarwal, N. K., Peterson, T. R., Addona, T. A., Keshishian, H., Carr, S. A., Magnuson, M. A., Sabatini, D. M., and Sarbassov dos, D. (2010) Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2. Mol. Cancer Res. 8, 896-906
43. Li, W., You, L., Cooper, J., Schiavon, G., Pepe-Caprio, A., Zhou, L., Ishii, R., Giovannini, M., Hanemann, C. O., Long, S. B., Erdjument-Bromage, H., Zhou, P., Tempst, P., and Giancotti, F. G. (2010) Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140, 477-490
44. Guillaud, L., Setou, M., and Hirokawa, N. (2003) KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons. J. Neurosci. 23, 131-140 (Pubitemid 36050412)
45. Chen, J. K., Taipale, J., Cooper, M. K., and Beachy, P. A. (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743-2748 (Pubitemid 35253140)
46. Bigelow, R. L., Chari, N. S., Unden, A. B., Spurgers, K. B., Lee, S., Roop, D. R., Toftgard, R., and McDonnell, T. J. (2004) Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J. Biol. Chem. 279, 1197-1205 (Pubitemid 38082643)
47. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884 (Pubitemid 3008389)
48. Chen, W. S., Xu, P. Z., Gottlob, K., Chen, M. L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K., Kadowaki, T., and Hay, N. (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (Pubitemid 32843832)
49. Hui, C. C., and Angers, S. (2011) Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol. 27, 513-537
50. Voorzanger, N., Touitou, R., Garcia, E., Delecluse, H. J., Rousset, F., Joab, I., Favrot, M. C., and Blay, J. Y. (1996) Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res. 56, 5499-5505 (Pubitemid 27011386)
51. Riobó, N. A., Lu, K., Ai, X., Haines, G. M., and Emerson, C. P., Jr. (2006) Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc. Natl. Acad. Sci. U.S.A. 103, 4505-4510
52. Rao, G., Pedone, C. A., Del Valle, L., Reiss, K., Holland, E. C., and Fults, D. W. (2004) Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 23, 6156-6162 (Pubitemid 39178868)
53. Wang, Y., Ding, Q., Yen, C. J., Xia, W., Izzo, J. G., Lang, J. Y., Li, C. W., Hsu, J. L., Miller, S. A., Wang, X., Lee, D. F., Hsu, J. M., Huo, L., Labaff, A. M., Liu, D., Huang, T. H., Lai, C. C., Tsai, F. J., Chang, W. C., Chen, C. H., Wu, T. T., Buttar, N. S., Wang, K. K., Wu, Y., Wang, H., Ajani, J., and Hung, M. C. (2012) The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell 21, 374-387